
Pulmonologist

No OPD information available
Lung Transplant
Bronchiolitis Obliterans
Chylous Ascites
Acute Interstitial Pneumonia
Cystic Fibrosis
Heart Transplant
Interstitial Lung Disease
Lymphangioleiomyomatosis
Actinic Keratosis
Alpha-1 Antitrypsin Deficiency (AATD)
Antisynthetase Syndrome
Ascites
Basal Cell Skin Cancer
Bowen's Disease
Bronchitis
Chronic Graft Versus Host Disease (cGvHD)
Chronic Obstructive Pulmonary Disease (COPD)
Endoscopy
Flu
Gastroesophageal Reflux Disease (GERD)
Graft Versus Host Disease (GvHD)
Idiopathic Pulmonary Fibrosis
Liver Transplant
Myositis
Parainfluenza
Pneumonia
Pulmonary Alveolar Proteinosis
Pulmonary Fibrosis
Pulmonary Hypertension
Respiratory Syncytial Virus (RSV) Infection
Squamous Cell Skin Carcinoma
Subcutaneous Emphysema
Subependymoma
Swallowing Difficulty
Allan R. Glanville is a male medical professional who helps patients with various lung and respiratory issues like lung transplant, pneumonia, and chronic obstructive pulmonary disease. He also treats conditions like skin cancer and difficulty swallowing.
He is skilled in performing procedures like endoscopy and stays updated on the latest medical research to provide the best care for his patients. Allan R. Glanville communicates effectively with patients, earning their trust through his expertise and compassionate approach.
In his work, Allan R. Glanville collaborates with other medical professionals to ensure comprehensive care for his patients. His dedication to improving patients' lives is evident through his positive impact on their health outcomes.
One of his notable publications discusses the impact of environmental exposures on lung disease development. He is also involved in a clinical trial to assess the efficacy of a treatment for pulmonary emphysema.
Overall, Allan R. Glanville is a dedicated and knowledgeable medical professional who uses his expertise to help patients with various respiratory conditions. His commitment to staying informed on the latest advancements in his field and his collaborative approach with colleagues make him a trusted and effective healthcare provider.
Enrollment Status: Active not recruiting
Published: January 15, 2025
Intervention Type: Biological, Other
Study Drug: Prolastin C
Study Phase: Phase 3
